European Medicines Agency (EMA)

EMA rates cities wanting to be its new home

International accessibility for delegates and staff, and education and employment possibilities for their families are some of the most important rating criteria.…

EMA hosts meeting to speed up patient access to new drugs

Easier access to medicines for EU citizens has taken a step forward after a first meeting of the European Medicines Agency (EMA) and European Union healthcare payers.…

PGEU sets out best practice on pharmacovigilance and risk minimisation

The Pharmaceutical Group of the European Union has published a new Best Practice Paper on Pharmacovigilance and Risk Minimisation.…

Steroid inhalers linked to increased risk of mycobacterial infection

Use of steroid inhalers for asthma and chronic obstructive pulmonary disease increases the risk of mycobacterial infections, according to a study published in the European Respiratory Journal.…

European Medicines Agency to host AMR summit

The European Medicines Agency (EMA) is to host a summit meeting with doctors’ and patients’ organisations, academics, EU member states and the World Health Organization (WHO) to discuss how collaboration can help tackle antimicrobial resistance (AMR).…

UK government wants close scientific ties with Europe after Brexit

The UK government has said it wants to negotiate a post-Brexit deal that ensures “strengthened collaboration” with European partners in medical, scientific and technological research.…

EMA surveys pharmacists on their awareness of side-effect reporting

The European Medicines Agency (EMA) has launched a survey for patients, pharmacists, doctors, nurses and other healthcare professionals to test their awareness of the arrangements for reporting drug reactions.…

EMA recommends modified-release paracetamol be removed from the market

Modified or prolonged-release paracetamol products should be removed from the market, the European Medicines Agency (EMA) has recommended.…

FDA and EMA sign confidentiality commitment

Medicine inspectors in the European Union will be given access to secret and commercially sensitive information by the Food and Drug Administration (FDA) in the US, after signing a new confidentiality commitment.…

EMA consults on tailoring medication for older people

A public consultation from the European Medicines Agency, which could lead to more medications tailored to suit older people, has been welcomed by a consultant pharmacist…